Variability in patient preparation for prostate biopsy among American urologists

Shandera, Kevin C.; Thibault, Gregory P.; Deshon, George E.

doi:10.1016/s0090-4295(98)00313-6

Cited by 114 publications

(62 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Large surveys in the USA and UK showed a tremendous number of regimens in type, route and duration of the given antibiotics. 15 Protocols must be standardized in daily practice to reduce the morbidity and mortality related to TRUS biopsy that has been observed in recent years, especially as a result of bacterial strains resistant to antibiotic prophylactic treatment. 16 In the present study, patients with prostatitis were admitted despite their ongoing prophylaxis treatment.…”

Section: Discussionmentioning

confidence: 99%

Acute bacterial prostatitis after transrectal ultrasound‐guided prostate biopsy: Epidemiological, bacteria and treatment patterns from a 4‐year prospective study

et al. 2013

View full text Add to dashboard Cite

Abbreviations & AcronymsObjectives: To evaluate the incidence, and clinical and bacterial features of iatrogenic prostatitis within 1 month after transrectal ultrasound-guided biopsy for detection of prostate cancer. Methods: From January 2006 to December 2009, 3000 patients underwent a 21-core transrectal ultrasound-guided prostate biopsy at Henri Mondor Hospital (Créteil, France) and were prospectively followed. All patients had a fluoroquinolone antimicrobial prophylaxis for 7 days. The primary study end-point was to evaluate the incidence of iatrogenic acute prostatitis within 1 month after the biopsy. The secondary end-point was to analyze the clinical and the bacterial features of the prostatitis. Results: Overall, 20 patients of the entire study population (0.67%) had an acute bacterial prostatitis within 2.90 ± 1.77 days (range 1-7 days) after the transrectal ultrasound-guided biopsy. The groups of patients with (n = 20) and without (n = 2980) infection were similar in terms of age, prostate-specific antigen level and prostate volume. Escherichia coli was the only isolated bacteria. The subsequent tests for antibiotic susceptibility showed a 95% resistance for fluroquinolone and amoxicillin. Resistance to amoxiclav, trimethoprimsulfamethoxazole, third generation cephalosporin and amikacin was 70%, 70%, 25% and 5% respectively. No resistance to imipenem was reported. They were all admitted for treatment without the need of intensive care unit referral. Complete recovery was achieved after 21.4 ± 7 days of antibiotic treatment. Conclusions: A fluroquinolone-based regimen still represents an appropriate prophylaxis protocol to minimize the risk of acute prostatitis secondary to prostate biopsy. Patients should be provided the appropriate care soon after the onset of the symptoms. An intravenous third generation cephalosporin or imipenem-based therapy seem to provide satisfying results.

show abstract

Section: Discussionmentioning

confidence: 99%

Acute bacterial prostatitis after transrectal ultrasound‐guided prostate biopsy: Epidemiological, bacteria and treatment patterns from a 4‐year prospective study

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Many reports indicate that antibiotic prophylaxis decreases the incidence of symptomatic infections, but the optimal prophylactic regimen has not yet been established [5]. Fluoroquinolones provide a broadspectrum coverage for Escherichia coli, which is the most common etiologic agent in infections after prostate biopsy [6].…”

Section: Introductionmentioning

confidence: 99%

Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora

Eruz

Yalçı

Özden

et al. 2017

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: In this study, we aimed to identify risk factors for the development of infectious complications after prostate biopsy and to investigate the role of intestinal colonization of bacteria that are resistant to prophylactic antibiotics. Methodology: A total of 168 patients who had undergone transrectal prostate biopsy (TRPB) under ciprofloxacin and gentamycin prophylaxis were included in the study. Stool cultures and subsequent antibiotic susceptibility testing were performed in all patients before the start of antibiotic prophylaxis. Results: Of the 168 patients, 17 (10.1%) developed urinary tract infection (UTI), while 6 (3.57%) developed sepsis within seven days after biopsy. Ciprofloxacin-resistant bacterial colonization was detected in 81 (48.2%) of the patients. None of the patients with ciprofloxacinsensitive bacteria in intestinal flora developed a UTI. The colonization of intestinal ciprofloxacin-resistant bacteria increased UTI risk significantly after TRPB (p < 0.0001). Urolithiasis history, presence of permanent urinary catheterization, hospitalization history for more than 48 hours in the last year, and recent antibiotic usage significantly increased UTI risk after TRPB. Conclusions: Development of an infection was more frequent in patients with resistant bacterial colonization. We hope to guide more comprehensive studies designed to find a standard prophylactic regimen for TRPB that can be used all over the world.

show abstract

“…There are 11 different antibiotics that have been used before TRUS biopsy in the recent literature including penicillin-based beta-lactamase inhibitors and aminoglycosides (amikacin and gentamicin) [10]. We used the same quinolone regimen (500 mg ciprofloxacin twice a daily orally, starting one day before the biopsy, lasting 7 days) for all patients.…”

Section: Discussionmentioning

confidence: 99%

“…There are many different bowel preparation protocols, but there is no standardized consensus among urologists [10]. This study was aimed at evaluating the effects of self-administrated phosphate enema versus sennasoid a-b calcium laxatives on post-biopsy urosepsis.…”

Section: Infectionsmentioning

confidence: 99%

The comparison of the influence between two different bowel preparation methods on sepsis after prostate biopsies

Yıldırım¹,

Badem²,

Cavis³

et al. 2015

CEJU

View full text Add to dashboard Cite

Introduction Transrectal ultrasonography (TRUS) guided prostate needle biopsy has been performed to diagnose and stage prostate cancer for many years. There are many different bowel preparation protocols to diminish the infectious complications, but there is no standardized consensus among urologists. Therefore, we aimed to assess two different bowel preparation methods on the rate of infectious complications in patients who underwent TRUS-guided prostate biopsy. Material and methods A total of 387 cases of TRUS-guided prostate biopsy were included in this retrospective study. All patients received antibiotic prophylaxis with ciprofloxacin (500 mg) twice a day orally for 7 days starting on the day before the biopsy. The patients were divided into two groups according to the bowel preparation method used. Patients (Group 1, n = 164) only received self-administrated phosphate enema) on the morning of the prostate biopsy. Other patients (Group 2, n = 223) received sennasoid a-b laxatives the night before the prostate biopsy. Infectious complications were classified as sepsis, fever (greater than 38°C) without sepsis, and other clinical infections. Results Major complications developed in 14 cases (3.8%), including 3 cases (0.8%) of urinary retention, and 11 (3%) infectious complications, all of which were sepsis. There were 3 and 8 cases of urosepsis in Group 1 and Group 2, respectively. There were no statistically significant differences between both Groups regarding to the rates of urosepsis (p = 0.358). Conclusions Despite both methods of bowel preparation, sodium phosphate enema or sennasoid a-b calcium laxatives, before TRUS-guided prostate biopsy have similar effect on the rate of urosepsis, so both methods of bowel preparation can be safely used.

show abstract

Variability in patient preparation for prostate biopsy among American urologists

Cited by 114 publications

References 5 publications

Acute bacterial prostatitis after transrectal ultrasound‐guided prostate biopsy: Epidemiological, bacteria and treatment patterns from a 4‐year prospective study

Acute bacterial prostatitis after transrectal ultrasound‐guided prostate biopsy: Epidemiological, bacteria and treatment patterns from a 4‐year prospective study

Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora

The comparison of the influence between two different bowel preparation methods on sepsis after prostate biopsies

Contact Info

Product

Resources

About